Wilma Williams Education and Clinical Research Grant for Endometrial Cancer supports researchers' precision-based clinical and translational studies to improve outcomes in high-risk endometrial cancer.
Funder: Foundation for Women's Cancer
Due Dates: October 7, 2026 (LOI) | December 9, 2026 (Invited full proposal)
Funding Amounts: $50,000 for one year
Summary: Supports precision-based clinical and translational research to improve outcomes in high-risk and poor-prognosis endometrial cancer.
Key Information: Research must take place at a U.S. institution; non-SGO members need a documented SGO co-investigator or sponsor.
The Foundation for Women’s Cancer (FWC) offers this grant through its 2026–2027 Endometrial/Uterine Cancer Grants program. It supports research to improve outcomes for patients with high-risk and poor-prognosis endometrial cancer, including serous tumors and sarcomas.
Priority goes to clinical and translational studies integrating precision-based tools and molecular diagnostics, including ctDNA, genomic and gene-expression profiling, proteomics, and other emerging technologies. These approaches should improve risk stratification, guide treatment selection, monitor therapeutic response, and identify mechanisms of resistance. The grant honors Wilma Williams and the work and dedication of gynecologic oncologists, with support from Dr. James Orr and Mrs. Vicki Orr.